Quantcast
Home > Quotes > URGN

UroGen Pharma Ltd. Ordinary Shares (URGN) Quote & Summary Data

URGN 
$47.29
*  
1.53
3.34%
Get URGN Alerts
*Delayed - data as of Dec. 18, 2018  -  Find a broker to begin trading URGN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    URGN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
Today's High / Low
$ 47.74 / $ 44.25
Share Volume
140,118
50 Day Avg. Daily Volume
73,020
Previous Close
$ 45.76
52 Week High / Low
$ 69.5676 / $ 36.95
Market Cap
761,475,734
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
140,118
50 Day Avg. Daily Volume:
73,020

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -4.04

Trading Range

The current last sale of $47.29 is 27.98% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 47.74 $ 69.5676
 Low: $ 44.25 $ 36.95

Company Description (as filed with the SEC)

Our legal and commercial name is UroGen Pharma Ltd. We are a company organized under the laws of State of Israel. We were formed in 2004 with an indefinite duration. We are registered with the Israeli Registrar of Companies. Our principal executive offices are located at 9 Ha'Ta'asiya Street, Ra'anana 4365007, Israel. Our telephone number is +972 (9) 770-7601. Investors should contact us for any inquiries through the address and telephone number of our principal executive office. We maintain a web site at http://www.urogen.com. The reference to our website is an inactive textual reference only and the information contained in, or that can be accessed through, our web site is not a part of this annual report. Urogen Pharma, Inc., our wholly-owned subsidiary, was incorporated on October 25, 2015 under the laws of the State of Delaware. Urogen Pharma, Inc.  ... More ...  


Risk Grade

Where does URGN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 45.79
Open Date:
Dec. 18, 2018
Close Price:
$ 47.29
Close Date:
Dec. 18, 2018

Consensus Recommendation

Analyst Info